LIke ThisLIke ThisLIke This

Ellis  Neufeld, MD, PhD

Ellis Neufeld
Research Center:
Dana-Farber/Boston Children’s Cancer and Blood Disorders Center
Medicine Research
Hematology/Oncology Research
Hospital Title:
Associate Chief
Academic Title:
Professor of Pediatrics, Harvard Medical School
Research Focus Area:
Bleeding disorders
Contact Via Email
Send an email to SendYour Name*Your Email Address*Subject*Comments*

Research Overview

Dr. Neufeld’s main research focus is clinical trials in non-malignant blood disorders, including thalassemia and iron overload, Immune Thrombocytopenia (ITP), and hemophilia. He is presently overall principal investigator for two international phase 2 trials of a novel oral iron chelator.

Dr. Neufeld's laboratory studies candidate genes for inherited blood disorders. His group elucidated the thiamine transporter gene, SLC19A2, as the cause of the syndrome of thiamine-responsive megaloblastic anemia (TRMA) with diabetes and deafness, among other disorders.

About Ellis Neufeld

Ellis Neufeld received his MD and PhD degrees from Washington University in St. Louis. He completed training in Pediatrics, Hematology and Medical Genetics at Boston Children's Hospital and Dana Farber Cancer Institute.

He is presently Associate Chief of the Division of Hematology/Oncology at Children's Hospital, Boston, and Professor of Pediatrics at Harvard Medical School, where he holds the Egan Family Foundation Chair in Transitional Medicine. He is co-chief of the Clinical Research Center at Boston Children’s, and he directs the Boston Hemophilia Center, a joint effort of Children’s and Brigham and Women’s Hospital. He also attends on the nonmalignant hematology service and the thrombosis service and anticoagulation program at Children's Hospital. He has published more than 130 papers, related to his research interests including clinical trials in hemophilia, ITP and thalassemia, and laboratory studies of candidate genes for inherited blood disorders. Dr. Neufeld is the Child Health Program Director for the NIH-sponsored Harvard Catalyst Clinical and Translational Sciences Program.

LIke ThisLIke ThisLIke This


Dana-Farber/Boston Children’s Cancer and Blood Disorders Center

Dana-Farber/Boston Children's Cancer and Blood Disorders Center is one of the top research centers in the world for pediatric cancers and blood diseases. It brings together laboratory scientists and clinical researchers from Dana-Farber Cancer Institute and Boston Children’s Hospital in a single program. We investigate pediatric cancers and non-malignant blood disorders from every angle—from examining cells under the microscope to tracking the effectiveness of current drug regimens using the most advanced molecular methods—so that we can create better treatments for children seen here and around the world.

Learn more